查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1930071

全球性传染病 (STD) 检测市场：市场规模、市场占有率、成长率、行业分析、依类型、应用和地区划分的考虑因素以及未来预测 (2026-2034)

Sexually Transmitted Diseases Testing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 162 Pages | 商品交期: 请询问到货日

价格

性传染病 (STD) 检测市场的成长因素

由于感染率上升、性健康意识增强以及政府主导的筛检计画扩大，全球性传染病 (STD) 检测市场正经历显着成长。根据 Fortune Business Insights 预测，该市场规模预计将在 2025 年达到 110.7 亿美元，从 2026 年的 119.7 亿美元增长到 2034 年的 239.5 亿美元，在预测期（2026-2034 年）内复合年增长率 (CAGR) 为 9.0%。

北美地区在 2025 年占全球市场主导地位，市占率达 42.80%。这得益于完善的医疗基础设施、公私合作以及政府主导的疾病检测强化措施。

市场动态

性传染病 (STD) 发生率的上升正在推动市场成长。

性传染病由细菌、病毒或寄生虫引起，经由性接触或母婴传染。由于许多性传染病没有症状，及时准确的诊断对于限制进一步感染至关重要。

根据全球估计：

  • 截至 2021 年，全球有 3,840 万人感染 HIV。
  • 全球 15 至 49 岁族群中有 4.91 亿人感染 HSV-2（2 型单纯疱疹病毒）。
  • 披衣菌感染、淋病、梅毒和 HIV 的高盛行率持续推动对检测试剂盒和诊断设备的需求。

某些人群中高风险性行为的增加、持续缺乏安全套使用以及性健康教育，进一步加剧了疾病负担。

市场趋势

从实验室检测到即时检测 (POCT) 的转变

性传染病检测市场最显着的趋势之一是从实验室检测逐步过渡到即时检测 (POCT)。儘管实验室检测在2026年仍以78.33%的市场占有率占主导地位，但预计在预测期内，即时检测（POC​​T）将以最高的复合年增长率增长。

即时侦测具有以下优点：

  • 更快的检测结果
  • 更低的检测成本
  • 更便捷的侦测途径
  • 减少社会歧视和隐私顾虑

这些优势正在加速医疗机构和患者在医院、诊所、药房和家庭医疗保健机构中采用即时检测解决方案。

市场区隔分析

依产品类型

  • 受高检测量和持续需求的推动，试剂和试剂盒在2026年占了79.32%的市场占有率。
  • 由于诊断实验室样本处理量的增加，预计仪器市场将稳定成长。

依应用领域

  • 由于衣原体感染率高且检测需求频繁，衣原体检测在2026年将占24.47%的市场占有率，成为市场主导。
  • 淋病、HIV和HPV检测也占了相当大的市场。
  • 由于常规筛检有限，梅毒和生殖器疱疹的市占率相对较低。

依最终使用者

  • 2026年，诊断中心凭藉着快速的服务和先进的诊断能力，占了52.34%的市场占有率，成为市场主导。
  • 医院和诊所紧随其后，尤其是在新兴国家。
  • 由于其隐私性和便利性优势，居家检测正受到越来越多的关注。

区域市场概况

  • 北美：预计到 2025 年，市场规模将达到 47.4 亿美元，主要得益于公私合作和公众意识提升项目。
  • 欧洲：先进的诊断基础设施和数位化结果交付系统将推动市场成长。
  • 亚太地区：预计成长将达到最高的复合年增长率，主要得益于政府主导的各项举措以及日本、中国和印度等国家公众意识的不断提高。
  • 拉丁美洲、中东和非洲：预期成长将较为温和，这主要得益于政府和非政府组织主导的公众意识提升计画的增加。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要国家主要疾病流行情形（2025 年）
  • 主要行业趋势
  • 主要国家和地区的监管概览
  • 性传染病 (STD) 检测市场的技术进步
  • COVID-19 对全球性传染病检测市场的影响

第五章 全球性传染病性传染病 (STD) 检测市场分析、洞察与预测 (2021-2034)

  • 市场分析、洞察与预测：依产品类型划分
    • 设备
    • 试剂和试剂盒
  • 市场分析、洞察与预测：依应用划分
    • 披衣菌感染
    • 梅毒
    • 生殖器疱疹
    • 淋病
    • 人类免疫缺乏病毒 (HIV)
    • 人类乳突病毒 (HPV)
    • 其他
  • 市场分析、洞察与预测：依检测场所划分
    • 临床检测
    • 即时侦测 (POC)
  • 市场分析、洞察与预测：依最终用户划分
    • 医院和诊所
    • 诊断中心
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美性传染病检测市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲性传染病（STD）检测市场分析：洞察与预测（2021-2034）

  • 依国家/地区
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 斯堪的纳维亚半岛
    • 欧洲其他地区

第八章：亚太地区性传染病检测市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章：拉丁美洲性传染病（STD）检测市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 其他拉丁美洲国家国家/地区

第十章：中东与非洲性传染病检测市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会 (GCC) 国家/地区
    • 南非
    • 其他中东和非洲国家/地区

第11章 竞争分析

  • 世界市场占有率分析(2025年)
  • 企业简介
  • Abbott
  • F. Hoffmann-La Roche Ltd
  • Becton, Dickinson and Company(BD)
  • Hologic, Inc.
  • Danaher Corporation
  • Thermo Fisher Scientific Inc.
  • bioMerieux, Inc.
  • Bio-Rad Laboratories, Inc.
  • DiaSorin Inc.
Product Code: FBI101095

Growth Factors of sexually transmitted diseases (STD) testing Market

The global sexually transmitted diseases (STD) testing market is witnessing strong growth due to rising infection rates, increasing awareness of sexual health, and expanding government-led screening initiatives. According to Fortunes Business Insights, the market was valued at USD 11.07 billion in 2025 and is projected to grow from USD 11.97 billion in 2026 to USD 23.95 billion by 2034, registering a CAGR of 9.10% during the forecast period (2026-2034).

North America dominated the global market in 2025, accounting for 42.80% market share, supported by robust healthcare infrastructure, public-private partnerships, and strong government initiatives to enhance disease detection.

Market Dynamics

Rising Incidence of STDs Driving Market Growth

Sexually transmitted diseases are caused by bacteria, viruses, or parasites and are transmitted through sexual contact or vertically from mother to child. Many STDs are asymptomatic, making timely and accurate diagnosis critical to limit further transmission.

According to global estimates:

  • 38.4 million people were living with HIV in 2021
  • 491 million people aged 15-49 had HSV-2 infection worldwide
  • High incidence rates of chlamydia, gonorrhea, syphilis, and HIV continue to increase demand for testing kits and diagnostic instruments

Increasing risky sexual behavior, lack of consistent condom usage, and limited sexual health education in certain populations are further contributing to the growing disease burden.

Market Trends

Shift from Laboratory Testing to Point-of-Care Testing

One of the most notable trends in the STD testing market is the gradual shift from laboratory-based testing to point-of-care testing (POCT). While laboratory testing dominated the market in 2026 with a share of 78.33%, POCT is expected to grow at the highest CAGR during the forecast period.

Point-of-care tests offer:

  • Faster turnaround time
  • Lower testing costs
  • Improved accessibility
  • Reduced stigma and confidentiality concerns

These benefits are encouraging healthcare providers and patients to adopt POCT solutions across hospitals, clinics, pharmacies, and homecare settings.

Segmentation Analysis

By Product Type

  • Reagents & kits dominated the market in 2026, holding 79.32% share, driven by high testing volumes and recurring demand.
  • Instruments are expected to grow steadily due to rising sample throughput in diagnostic laboratories.

By Application

  • Chlamydia testing led the market in 2026 with a 24.47% share, owing to its high prevalence and frequent testing requirements.
  • Gonorrhea, HIV, and HPV also accounted for significant market shares.
  • Syphilis and genital herpes held comparatively lower shares due to limited routine screening.

By End User

  • Diagnostic centers dominated the market in 2026 with 52.34% share, supported by faster service delivery and advanced diagnostic capabilities.
  • Hospitals & clinics followed, especially in emerging economies.
  • Home-based testing is gaining traction due to privacy and convenience benefits.

Regional Insights

  • North America: Market valued at USD 4.74 billion in 2025; strong growth driven by public-private partnerships and awareness programs.
  • Europe: Growth supported by advanced diagnostic infrastructure and digital result delivery systems.
  • Asia Pacific: Expected to grow at the highest CAGR, supported by government initiatives and rising awareness in countries such as Japan, China, and India.
  • Latin America & Middle East & Africa: Moderate growth due to increasing government and NGO-led awareness programs.

Competitive Landscape

The global STD testing market is fragmented, with major players including:

  • Abbott
  • F. Hoffmann-La Roche Ltd
  • bioMerieux
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • BD
  • Hologic, Inc.

These companies are focusing on R&D investments, strategic collaborations, and product launches to expand their global presence.

Conclusion

The global sexually transmitted diseases testing market is set for strong expansion from 2026 to 2034, driven by rising disease prevalence, growing awareness, and increasing adoption of point-of-care testing solutions. With the market expected to reach USD 23.95 billion by 2034, continued government initiatives, technological advancements, and improved accessibility to testing will play a crucial role in shaping market growth. Despite challenges such as stigma and reluctance toward testing, sustained efforts by healthcare authorities and industry players are expected to significantly strengthen STD detection and prevention worldwide.

Segmentation By Product Type, Application, Setting, End User, and Region

By Product Type * Instruments

  • Reagents & Kits

By Application * Chlamydia

  • Syphilis
  • Genital Herpes
  • Gonorrhea
  • Human Immunodeficiency Virus
  • Human Papillomavirus
  • Others

By Setting * Laboratory Testing

  • Point-of-Care

By End User * Hospital & Clinics

  • Diagnostic Centers
  • Others

By Region * North America (By Product Type, By Application, By Setting, By End User, By Country)

    • U.S.
    • Canada
  • Europe (By Product Type, By Application, By Setting, By End User, By Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product Type, By Application, By Setting, By End User, By Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, By Application, By Setting, By End User, By Country/ Sub-Region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, By Application, By Setting, By End User, By Country/Sub-Region)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Diseases, By Key Countries, 2025
  • 4.2. Key Industry Developments
  • 4.3. Overview of Regulatory Scenario, By Key Countries/Regions
  • 4.4. Technological Advancements in Sexually Transmitted Diseases Testing Market
  • 4.5. Impact of COVID-19 on Global Sexually Transmitted Diseases Testing Market

5. Global Sexually Transmitted Diseases Testing Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Instruments
    • 5.1.2. Reagents & Kits
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Chlamydia
    • 5.2.2. Syphilis
    • 5.2.3. Genital Herpes
    • 5.2.4. Gonorrhea
    • 5.2.5. Human Immunodeficiency Virus
    • 5.2.6. Human Papillomavirus (HPV)
    • 5.2.7. Others
  • 5.3. Market Analysis, Insights and Forecast - By Setting
    • 5.3.1. Laboratory Testing
    • 5.3.2. Point-of Care (POC)
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Hospitals and Clinics
    • 5.4.2. Diagnostic Centers
    • 5.4.3. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Sexually Transmitted Diseases Testing Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Instruments
    • 6.1.2. Reagents & Kits
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Chlamydia
    • 6.2.2. Syphilis
    • 6.2.3. Genital Herpes
    • 6.2.4. Gonorrhea
    • 6.2.5. Human Immunodeficiency Virus
    • 6.2.6. Human Papillomavirus (HPV)
    • 6.2.7. Others
  • 6.3. Market Analysis, Insights and Forecast - By Setting
    • 6.3.1. Laboratory Testing
    • 6.3.2. Point-of Care (POC)
  • 6.4. Market Analysis, Insights and Forecast - By End User
    • 6.4.1. Hospitals and Clinics
    • 6.4.2. Diagnostic Centers
    • 6.4.3. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Sexually Transmitted Diseases Testing Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Instruments
    • 7.1.2. Reagents & Kits
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Chlamydia
    • 7.2.2. Syphilis
    • 7.2.3. Genital Herpes
    • 7.2.4. Gonorrhea
    • 7.2.5. Human Immunodeficiency Virus
    • 7.2.6. Human Papillomavirus (HPV)
    • 7.2.7. Others
  • 7.3. Market Analysis, Insights and Forecast - By Setting
    • 7.3.1. Laboratory Testing
    • 7.3.2. Point-of Care (POC)
  • 7.4. Market Analysis, Insights and Forecast - By End User
    • 7.4.1. Hospitals and Clinics
    • 7.4.2. Diagnostic Centers
    • 7.4.3. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 7.5.1. U.K
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Sexually Transmitted Diseases Testing Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Instruments
    • 8.1.2. Reagents & Kits
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Chlamydia
    • 8.2.2. Syphilis
    • 8.2.3. Genital Herpes
    • 8.2.4. Gonorrhea
    • 8.2.5. Human Immunodeficiency Virus
    • 8.2.6. Human Papillomavirus (HPV)
    • 8.2.7. Others
  • 8.3. Market Analysis, Insights and Forecast - By Setting
    • 8.3.1. Laboratory Testing
    • 8.3.2. Point-of Care (POC)
  • 8.4. Market Analysis, Insights and Forecast - By End User
    • 8.4.1. Hospitals and Clinics
    • 8.4.2. Diagnostic Centers
    • 8.4.3. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Sexually Transmitted Diseases Testing Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Instruments
    • 9.1.2. Reagents & Kits
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Chlamydia
    • 9.2.2. Syphilis
    • 9.2.3. Genital Herpes
    • 9.2.4. Gonorrhea
    • 9.2.5. Human Immunodeficiency Virus
    • 9.2.6. Human Papillomavirus (HPV)
    • 9.2.7. Others
  • 9.3. Market Analysis, Insights and Forecast - By Setting
    • 9.3.1. Laboratory Testing
    • 9.3.2. Point-of Care (POC)
  • 9.4. Market Analysis, Insights and Forecast - By End User
    • 9.4.1. Hospitals and Clinics
    • 9.4.2. Diagnostic Centers
    • 9.4.3. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Sexually Transmitted Diseases Testing Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Instruments
    • 10.1.2. Reagents & Kits
  • 10.2. Market Analysis, Insights and Forecast - By Application
    • 10.2.1. Chlamydia
    • 10.2.2. Syphilis
    • 10.2.3. Genital Herpes
    • 10.2.4. Gonorrhea
    • 10.2.5. Human Immunodeficiency Virus
    • 10.2.6. Human Papillomavirus (HPV)
    • 10.2.7. Others
  • 10.3. Market Analysis, Insights and Forecast - By Setting
    • 10.3.1. Laboratory Testing
    • 10.3.2. Point-of Care (POC)
  • 10.4. Market Analysis, Insights and Forecast - By End User
    • 10.4.1. Hospitals and Clinics
    • 10.4.2. Diagnostic Centers
    • 10.4.3. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-Region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
    • 11.2.1. Abbott
      • 11.2.1.1. Overview,
      • 11.2.1.2. Product,
      • 11.2.1.3. SWOT Analysis,
      • 11.2.1.4. Recent Developments,
      • 11.2.1.5. Strategies,
      • 11.2.1.6. financials (Based on Availability)
    • 11.2.2. F. Hoffmann-La Roche Ltd
      • 11.2.2.1. Overview,
      • 11.2.2.2. Product,
      • 11.2.2.3. SWOT Analysis,
      • 11.2.2.4. Recent Developments,
      • 11.2.2.5. Strategies,
      • 11.2.2.6. financials (Based on Availability)
    • 11.2.3. Becton, Dickinson and Company (BD)
      • 11.2.3.1. Overview,
      • 11.2.3.2. Product,
      • 11.2.3.3. SWOT Analysis,
      • 11.2.3.4. Recent Developments,
      • 11.2.3.5. Strategies,
      • 11.2.3.6. financials (Based on Availability)
    • 11.2.4. Hologic, Inc.
      • 11.2.4.1. Overview,
      • 11.2.4.2. Product,
      • 11.2.4.3. SWOT Analysis,
      • 11.2.4.4. Recent Developments,
      • 11.2.4.5. Strategies,
      • 11.2.4.6. financials (Based on Availability)
    • 11.2.5. Danaher Corporation
      • 11.2.5.1. Overview,
      • 11.2.5.2. Product,
      • 11.2.5.3. SWOT Analysis,
      • 11.2.5.4. Recent Developments,
      • 11.2.5.5. Strategies,
      • 11.2.5.6. financials (Based on Availability)
    • 11.2.6. Thermo Fisher Scientific Inc.
      • 11.2.6.1. Overview,
      • 11.2.6.2. Product,
      • 11.2.6.3. SWOT Analysis,
      • 11.2.6.4. Recent Developments,
      • 11.2.6.5. Strategies,
      • 11.2.6.6. financials (Based on Availability)
    • 11.2.7. bioMerieux, Inc.
      • 11.2.7.1. Overview,
      • 11.2.7.2. Product,
      • 11.2.7.3. SWOT Analysis,
      • 11.2.7.4. Recent Developments,
      • 11.2.7.5. Strategies,
      • 11.2.7.6. financials (Based on Availability)
    • 11.2.8. Bio-Rad Laboratories, Inc.
      • 11.2.8.1. Overview,
      • 11.2.8.2. Product,
      • 11.2.8.3. SWOT Analysis,
      • 11.2.8.4. Recent Developments,
      • 11.2.8.5. Strategies,
      • 11.2.8.6. financials (Based on Availability)
    • 11.2.9. DiaSorin Inc.
      • 11.2.9.1. Overview,
      • 11.2.9.2. Product,
      • 11.2.9.3. SWOT Analysis,
      • 11.2.9.4. Recent Developments,
      • 11.2.9.5. Strategies,
      • 11.2.9.6. financials (Based on Availability)

List of Tables

  • Table 01: Global Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 02: Global Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 03: Global Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Setting, 2021-2034
  • Table 04: Global Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 05: Global Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Region, 2021-2034
  • Table 06: North America Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 07: North America Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 08: North America Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Setting, 2021-2034
  • Table 09: North America Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 10: North America Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 12: Europe Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 13: Europe Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Setting, 2021-2034
  • Table 14: Europe Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 15: Europe Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2021-2034
  • Table 16: Asia Pacific Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 17: Asia Pacific Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 18: Asia Pacific Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Setting, 2021-2034
  • Table 19: Asia Pacific Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 20: Asia Pacific Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2021-2034
  • Table 21: Latin America Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 22: Latin America Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 23: Latin America Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Setting, 2021-2034
  • Table 24: Latin America Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 25: Latin America Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2021-2034
  • Table 26: Middle East & Africa Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Product Type, 2021-2034
  • Table 27: Middle East & Africa Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Application, 2021-2034
  • Table 28: Middle East & Africa Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Setting, 2021-2034
  • Table 29: Middle East & Africa Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By End User, 2021-2034
  • Table 30: Middle East & Africa Sexually Transmitted Diseases Testing Market Revenue (USD billion) Forecast, By Country/Sub-Region, 2021-2034

List of Figures

  • Figure 01: Global Sexually Transmitted Diseases Testing Market Value Share (%), By Product Type, 2025 & 2034
  • Figure 02: Global Sexually Transmitted Diseases Testing Market Value Share (%), By Application, 2025 & 2034
  • Figure 03: Global Sexually Transmitted Diseases Testing Market Value Share (%), By Setting, 2025 & 2034
  • Figure 04: Global Sexually Transmitted Diseases Testing Market Value Share (%), By End User, 2025 & 2034
  • Figure 05: Global Sexually Transmitted Diseases Testing Market Value Share (%), By Region, 2025 & 2034
  • Figure 06: North America Sexually Transmitted Diseases Testing Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 07: North America Sexually Transmitted Diseases Testing Market Value Share (%), by Product Type, 2025
  • Figure 08: North America Sexually Transmitted Diseases Testing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 09: North America Sexually Transmitted Diseases Testing Market Value Share (%), by Application, 2025
  • Figure 10: North America Sexually Transmitted Diseases Testing Market Value (USD billion), by Setting, 2025 & 2034
  • Figure 11: North America Sexually Transmitted Diseases Testing Market Value Share (%), by Setting, 2025
  • Figure 12: North America Sexually Transmitted Diseases Testing Market Value (USD billion), by End User, 2025 & 2034
  • Figure 13: North America Sexually Transmitted Diseases Testing Market Value Share (%), by End User, 2025
  • Figure 14: North America Sexually Transmitted Diseases Testing Market Value (USD billion), by Country, 2025 & 2034
  • Figure 15: North America Sexually Transmitted Diseases Testing Market Value Share (%), by Country, 2025
  • Figure 16: Europe Sexually Transmitted Diseases Testing Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 17: Europe Sexually Transmitted Diseases Testing Market Value Share (%), by Product Type, 2025
  • Figure 18: Europe Sexually Transmitted Diseases Testing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 19: Europe Sexually Transmitted Diseases Testing Market Value Share (%), by Application, 2025
  • Figure 20: Europe Sexually Transmitted Diseases Testing Market Value (USD billion), by Setting, 2025 & 2034
  • Figure 21: Europe Sexually Transmitted Diseases Testing Market Value Share (%), by Setting, 2025
  • Figure 22: Europe Sexually Transmitted Diseases Testing Market Value (USD billion), by End User, 2025 & 2034
  • Figure 23: Europe Sexually Transmitted Diseases Testing Market Value Share (%), by End User, 2025
  • Figure 24: Europe Sexually Transmitted Diseases Testing Market Value (USD billion), by Country/Sub-Region, 2025 & 2034
  • Figure 25: Europe Sexually Transmitted Diseases Testing Market Value Share (%), by Country/Sub-Region, 2025
  • Figure 26: Asia Pacific Sexually Transmitted Diseases Testing Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 27: Asia Pacific Sexually Transmitted Diseases Testing Market Value Share (%), by Product Type, 2025
  • Figure 28: Asia Pacific Sexually Transmitted Diseases Testing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 29: Asia Pacific Sexually Transmitted Diseases Testing Market Value Share (%), by Application, 2025
  • Figure 30: Asia Pacific Sexually Transmitted Diseases Testing Market Value (USD billion), by Setting, 2025 & 2034
  • Figure 31: Asia Pacific Sexually Transmitted Diseases Testing Market Value Share (%), by Setting, 2025
  • Figure 32: Asia Pacific Sexually Transmitted Diseases Testing Market Value (USD billion), by End User, 2025 & 2034
  • Figure 33: Asia Pacific Sexually Transmitted Diseases Testing Market Value Share (%), by End User, 2025
  • Figure 34: Asia Pacific Sexually Transmitted Diseases Testing Market Value (USD billion), by Country/Sub-Region, 2025 & 2034
  • Figure 35: Asia Pacific Sexually Transmitted Diseases Testing Market Value Share (%), by Country/Sub-Region, 2025
  • Figure 36: Latin America Sexually Transmitted Diseases Testing Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 37: Latin America Sexually Transmitted Diseases Testing Market Value Share (%), by Product Type, 2025
  • Figure 38: Latin America Sexually Transmitted Diseases Testing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 39: Latin America Sexually Transmitted Diseases Testing Market Value Share (%), by Application, 2025
  • Figure 40: Latin America Sexually Transmitted Diseases Testing Market Value (USD billion), by Setting, 2025 & 2034
  • Figure 41: Latin America Sexually Transmitted Diseases Testing Market Value Share (%), by Setting, 2025
  • Figure 42: Latin America Sexually Transmitted Diseases Testing Market Value (USD billion), by End User, 2025 & 2034
  • Figure 43: Latin America Sexually Transmitted Diseases Testing Market Value Share (%), by End User, 2025
  • Figure 44: Latin America Sexually Transmitted Diseases Testing Market Value (USD billion), by Country/Sub-Region, 2025 & 2034
  • Figure 45: Latin America Sexually Transmitted Diseases Testing Market Value Share (%), by Country/Sub-Region, 2025
  • Figure 46: Middle East & Africa Sexually Transmitted Diseases Testing Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 47: Middle East & Africa Sexually Transmitted Diseases Testing Market Value Share (%), by Product Type, 2025
  • Figure 48: Middle East & Africa Sexually Transmitted Diseases Testing Market Value (USD billion), by Application, 2025 & 2034
  • Figure 49: Middle East & Africa Sexually Transmitted Diseases Testing Market Value Share (%), by Application, 2025
  • Figure 50: Middle East & Africa Sexually Transmitted Diseases Testing Market Value (USD billion), by Setting, 2025 & 2034
  • Figure 51: Middle East & Africa Sexually Transmitted Diseases Testing Market Value Share (%), by Setting, 2025
  • Figure 52: Middle East & Africa Sexually Transmitted Diseases Testing Market Value (USD billion), by End User, 2025 & 2034
  • Figure 53: Middle East & Africa Sexually Transmitted Diseases Testing Market Value Share (%), by End User, 2025
  • Figure 54: Middle East & Africa Sexually Transmitted Diseases Testing Market Value (USD billion), by Country/Sub-Region, 2025 & 2034
  • Figure 55: Middle East & Africa Sexually Transmitted Diseases Testing Market Value Share (%), by Country/Sub-Region, 2025